Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
Tags :Kellerhals Carrard
F.G. Pfister Holding acquires a 49% participation in Promet in Kirchberg (SG) via F.G. Pfister Beteiligungen. The company provides system solutions for energy engineering. Its main fields of activity are the planning and construction
The AISTS welcomes Prof. Edgar Philippin (pictured), partner of Kellerhals Carrard, as the new President of AISTS’ Foundation Council. The International Academy of Sport Science and Technology (AISTS), located in Lausanne, Switzerland is a
Kellerhals Carrard has acted as legal counsel to Stille, a medical device company, in acquiring all shares in Switzerland-based S&T, a manufacturer of microsurgical instruments, in exchange for CHF 6 million paid in cash
The Kursaal Bern, a traditional Swiss company with the three business segments congress center, hotel & gastronomy and casino, successfully launched the first initial public offering since the outbreak of the pandemic on the BX
One Swiss Bank and its shareholders entered into a merger agreement with Banque Profil de Gestion, which closed on June 1, 2021 following the grant of the necessary authorizations and the fulfilment of other conditions precedent pursuant
Private investment company Drs Investment sells 100 per cent of the shares in the Swiss software company Xelog to Prologistik Holding. The acquisition of Xelog, the Swiss logistics software specialist, is part of Prologistik’s strategy
ViboTec, the provider of an AI-based virtual advertising system for live sports, closes its seven-digit Seed Financing Round with Fraunhofer Tech Transfer Fund FTFF und the industry investors Dr. Nico Brunner, Hans-Milovan Halhuber and Bernd
MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany.
The Kellerhals Carrard Startup Desk acted as legal counsel to Qnami, a Quantum Tech startup, in closing its Series A Financing Round raising a total of CHF 4 million. Led by the Venture Capital Funds Runa
